Dixon started his surety career in 1981, owned North Coast Surety, a surety specialty insurance agency for fifteen years, and North Coast Surety Technologies (now Surety Resource Connection) before joining Wells Fargo (now USI), and an innovator for modernizing surety services with data analytics for streamlined underwriting, and predicti
Dixon started his surety career in 1981, owned North Coast Surety, a surety specialty insurance agency for fifteen years, and North Coast Surety Technologies (now Surety Resource Connection) before joining Wells Fargo (now USI), and an innovator for modernizing surety services with data analytics for streamlined underwriting, and predictive analytics for improved claims handling and response.
Don McQuade is Professor of English and American Studies at the University of California, Berkeley, where he also served in several leadership positions, including as Dean of Undergraduate and Interdisciplinary Studies, Acting Vice Provost, and Vice Chancellor for University Relations. He is well versed in leading and managing large, com
Don McQuade is Professor of English and American Studies at the University of California, Berkeley, where he also served in several leadership positions, including as Dean of Undergraduate and Interdisciplinary Studies, Acting Vice Provost, and Vice Chancellor for University Relations. He is well versed in leading and managing large, complex projects and organizations. An educational innovator and entrepreneur, he also co-founded and served as Chairman of WriteLab, leading it to a successful acquisition by a NYSE-listed company.
Larry has over 40 years of IT systems integration and Global Trade experience, starting as with the Apple Core group in 1979 with Steve Wozniak to currently serving as investor/mentor to 8 start-ups.
He led Accenture’s Global Trade practice with an emphasis in China. With CapGemini, he led Global Trade Systems integrations (SAP, Oracle &
Larry has over 40 years of IT systems integration and Global Trade experience, starting as with the Apple Core group in 1979 with Steve Wozniak to currently serving as investor/mentor to 8 start-ups.
He led Accenture’s Global Trade practice with an emphasis in China. With CapGemini, he led Global Trade Systems integrations (SAP, Oracle & others). As a Director of Gartner’s Supply Chain Analysts, he wrote about global innovation, RFID, SAP & Oracle, as well as covered over 50 IT companies.
He also led Intl Ops at Adobe (22 countries w 143 employees), Hewlett Packard, and Amdahl. With over 150 country visits, he continues to be open to new ideas to improve business.
Daniel Peter is Salesforce Practice Lead at Robots & Pencils. He is a 27x certified Salesforce MVP (one of the most certified in the world) who has been working in the ecosystem for 10 years and leads the Bay Area Salesforce Developer Group. Some of the highlights of last 10 years include building a manufacturing ERP on Salesforce call
Daniel Peter is Salesforce Practice Lead at Robots & Pencils. He is a 27x certified Salesforce MVP (one of the most certified in the world) who has been working in the ecosystem for 10 years and leads the Bay Area Salesforce Developer Group. Some of the highlights of last 10 years include building a manufacturing ERP on Salesforce called Kenandy, serving as an advisor for the Salesforce Accelerate program, and speaking at various Salesforce Conferences around the world.
Prior to his experience in the Salesforce ecosystem he has been a part of many technologies projects including North Coast Surety Technologies.
Daniel holds an MBA from the University of California, Davis and a Bachelors in Management Information Systems from California State University, Chico.
LinkedIn
Ms. Steele served as an advisor to Daré Bioscience Operations from the company’s inception in 2015, and following the company’s business combination with Cerulean Pharma in July 2017, she joined the Board of Directors of the renamed company, Daré Bioscience.
Ms. Steele previously served as Senior Vice President, General Counsel and Secret
Ms. Steele served as an advisor to Daré Bioscience Operations from the company’s inception in 2015, and following the company’s business combination with Cerulean Pharma in July 2017, she joined the Board of Directors of the renamed company, Daré Bioscience.
Ms. Steele previously served as Senior Vice President, General Counsel and Secretary of InterMune, a publicly-traded biopharmaceutical company, from 2004 to 2014. From 1998 to 2003, Ms. Steele served as Vice President of Legal Affairs for North America for Elan Pharmaceuticals, a publicly-traded pharmaceutical company.
Ms. Steele currently serves as a member of the board of directors of Alveo Technologies, a privately-held medical diagnostics company. Ms. Steele previously served as a member of the boards of directors of Alios Biopharma and Targanta Therapeutics, both of which were biotechnology companies focused on the research and development of therapeutic compounds prior to their respective acquisitions.
Ms. Steele received a BA from the University of Colorado, a JD from the University of California, Hastings College of the Law, and an LLM in Taxation from New York University School of Law.